The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that Mount Sinai School of Medicine is a new
NIAID is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance around the country. Mount Sinai will help expand NIAIDs influenza research as the only recognized
Mount Sinai welcomes this high honor bestowed by NIAID for our influenza virus research and recognition of our teams hard work, said Adolfo García-Sastre, PhD, principal investigator for research at Mount Sinais
The Mount Sinai Center of Excellence for Influenza Research and Surveillance has been named the Center for Research in Influenza Pathogenesis (CRIP). Mount Sinai researchers Adolfo García-Sastre and Peter Palese, in collaboration with Daniel Perez, at University of Maryland, and Ron Fouchier, at Erasmus Medical Center in Rotterdam, will continue to conduct molecular studies to identify influenza virus genes associated with the development of disease, the adaptability of flu viruses in birds and mammals, and the transmission of flu viruses between different hosts.
Further research in 2007, showed modest changes in the 1918 flu viruss hemagglutinin receptor binding site -- a molecular structure critical for the spread of infection -- stopped viral transmissions in ferrets. This recent study could have significant clinical implications in helping scientists develop ways to break the disease cycle and possibly help reduce the risk for a potential pandemic and illness.
The six Centers of Excellence for Influenza Research and Surveillance awards include: St. Jude Childrens Research Hospital (Memphis), University of California at Los Angeles (UCLA), University of Minnesota (Minneapolis), Emory University (Atlanta), Mount Sinai School of Medicine (New York City), and University of Rochester (Rochester, N.Y.).